Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

QUIA PHARMA

0.00 SEK

0.00 %

Less than 1K followers

QUIA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
0.00 %
-66.67 %
-73.68 %
-82.76 %
-88.28 %
-93.49 %
-99.98 %
-100.00 %
-100.00 %

QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.

Read more
Market cap
1.97M SEK
Turnover
17.74K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Press release2/21/2024, 5:40 PM

CORRECTION: QuiaPEG has submitted a formal application to Nasdaq in relation to the company’s acquisition of intellectual property rights from Rosemonkey Ltd.

QUIA PHARMA
Press release2/20/2024, 7:00 AM

QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.

QUIA PHARMA
Press release2/15/2024, 1:25 PM

QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement

QUIA PHARMA

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/8/2023, 7:22 AM

QuiaPEG enters conditional agreement on a reverse takeover and financing to enable continued business development of existing operations

QUIA PHARMA
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.